This study demonstrates improved biocompatibility and hemocompatibility in electrospun membranes incorporating Fe/Mg-HAP, suggesting their potential in tissue engineering.
This study investigates the effect of incorporating Fe/Mg-hydroxyapatite (Fe/Mg-HAP) nanoparticles into electrospun polycaprolactone (PCL) membranes, with a focus on surface wettability, morphology, biocompatibility and hemocompatibility for potential biomedical applications. The incorporation of Fe/Mg-HAP nanoparticles significantly enhanced the surface hydrophilicity, as evidenced by a decrease in the contact angle from 76.3º (PCL) to 67.4º (PFe/Mg-HAP), suggesting improved interaction with aqueous environments. Scanning electron microscopy (SEM) and roughness measurements revealed that Fe/Mg-HAP incorporation led to the increased surface roughness, which is beneficial for protein adsorption and cell attachment. Biocompatibility studies demonstrated that the PFe/Mg-HAP membranes maintained high cell viability (~85%), supporting their potential for tissue engineering applications. Hemocompatibility evaluations showed the minimal hemolytic activity, moderate platelet adhesion and stable coagulation profiles, indicating a favourable interaction with blood components. These results highlight the promising potential of Fe/Mg-HAP-incorporated electrospun PCL membranes for use in blood-contacting medical devices, wound healing and tissue engineering. The study highlights the importance of nanofiller incorporation in enhancing the physico-chemical properties of electrospun membranes, providing the solution for their future application in regenerative medicines.
No takes yet. Share an insight, caveat, or question.
Ganapathy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: